Login
Register

Journals

Contemporary Management of Moderate to Severe Plaque Psoriasis
December 26, 2017 – Jashin J. Wu, MD
Psoriasis and Psoriatic Arthritis Treatment
June 20, 2016 – Alan Menter, MD
Psoriasis and Psoriatic Arthritis Overview
June 17, 2016 – Alan Menter, MD
VIEW MORE >>>

Study Summaries

Tildrakizumab in Patients With Psoriasis: Three-Year Efficacy Results From reSURFACE 1 and reSURFACE 2 in Those With and Without Metabolic Syndrome
October 30, 2019
Four-Year Efficacy and Safety Outcomes From reSURFACE 1 and reSURFACE 2 in Patients Given Tildrakizumab for Plaque Psoriasis
October 30, 2019
The Use of Realized Prices and Real-World Outcomes Data in Assessments of Drug Value
October 30, 2019
Productivity Loss and Indirect Costs Due to Psoriasis in the United States
October 30, 2019
Poster Recap: Associations Among Opioid Use, Outpatient Visits, and Comorbidities in Patients With Moderate-to-Severe Psoriasis
September 27, 2019
Poster Recap: Comorbidities, Infections, and Treatments of Patients With Psoriasis
September 27, 2019
Poster Recap: Biologics and Apremilast Adherence Patterns of Patients With Moderate to Severe Plaque Psoriasis Grouped by Metabolic Syndrome Status
September 27, 2019
Poster Recap: Adherence Rates and Additional Treatment Patterns With Biologics and Apremilast for Moderate-to-Severe Plaque Psoriasis
September 27, 2019
ACCOUNTABLE CARE DELIVERY CONGRESS
CONTINUING EDUCATION
CONTRIBUTORS
MEETINGS
PARTICIPATE
COMPENDIA
In Focus Blog
Press Releases
Interactive Tools
Managed Care Podcast
Panel Discussions
Week In Review
Information for Reviewers
Information for Authors
Formulary Central
Clinical Study Summaries
Study Summaries
Resources
About Us
AJAC
AJMC
EBDM
EBO
Careers
Contact Us
Privacy Policy
Terms & Conditions
Subscribe
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.